Home › Merck's Vytorin first cholesterol drug to cut risk further
 

Keywords :   


Merck's Vytorin first cholesterol drug to cut risk further

2014-11-18 09:37:30| Biotech - Topix.net

Merck & Co.' s Vytorin reduced the risks of second heart attacks and strokes in patients already on aggressive therapy, making it the first medicine to improve on the current standard of care for lowering cholesterol.

Tags: further risk cut drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Boeing may face criminal prosecution, US says
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
15.05Renters in scrum for homes as listing time slashed
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
More »